Top clinical trial services provider from ClientPharma: We’re a specialist pharmaceutical supply company meeting global client requirements for clinical development. ClientPharma offers innovative sourcing and supply solutions from pre-clinical through to Phases I, II and III. Throughout the lifecycle of your drug development, it is our strategic approach that provides effective, tailored solutions that streamline the many complexities, avoiding supply chain disruptions and costly delays. Discover more information at risks of commercial drug sourcing supply.

Our highly experienced team is ready to hear from you. Please reach out to us with any questions or clinical supply requirements. We look forward to working with you and helping to make your clinical program a success! We Think of Everything, So You Don’t Have To: ClientPharma’s extensive experience and expertise means we provide both comprehensive and pragmatic guidance; delivering on point and on time – no matter how technically challenging.

Supplying the world’s most respected biopharmaceutical companies – ClientPharma handles the numerous challenges of obtaining medicines quickly, in multiple lots, with ranging expiry dating – and we can source and supply from any region in the world! Our deep understanding and skill gives you the visibility needed to fulfill your clinical trial project requirements: Proactive market research and insights Procurement planning services; Worldwide sourcing capabilities; Collection and collation of multiple batches; Provision of batch documentation; Extensive experience and knowledge of emerging markets.

Our temperature-controlled capabilities include 2°- 8°C and 15°- 25°C facilities, as well as access to specialist transport to manage deliveries around the world according to product temperature requirements. Extensive capabilities: Our capabilities include stock receipt, import & export expertise, in-territory regulatory specialists, product reconciliation and destruction services. You can trust us: Our highly trained logistics team is dedicated to providing a robust clinical trial supply chain and trusted product integrity with regulatory compliant distribution through validated temperature-controlled logistics. We provide the peace-of-mind you need, offering you with dedicated clinical trial supply chain solutions to meet the explicit needs of your clinical programs. Read additional information on https://www.clientpharma.com/.

Meeting the needs of global clinical supply trials requires diversity in supply strategies to address the unique complexities of each country’s healthcare and medication distribution systems. The “one-size fits all” approach is not a single supply strategy; instead, it leverages the expertise of a supply vendor partnership that addresses the need for a multi-faceted supply chain strategy. TrialCard Incorporated is a full-service life sciences commercialization partner that provides comprehensive solutions that span the entire biopharmaceutical value chain. In addition to a foundation of fully integrated, digitally enabled patient support services, its broader offerings include everything from late-stage clinical trial management to post-marketing HCP engagement services and proprietary data-as-a-service payer intelligence and insights. Founded in 2000, TrialCard provides commercialization needs for more than 160 life science customers and has connected over 35 million patients with more than $18 billion in branded drug savings to date. The company is headquartered in Morrisville, North Carolina.

Supply and demand of pharmaceuticals are mutually exclusive. The supply chain is wholly reliant upon pharmaceutical companies being able to effectively forecast demand for a particular product. The process of forecasting is often made difficult when a new medicine has just been brought to market or rapid deployment of a drug needs to happen in response to a pandemic due to a lack of concrete evidence to base estimations on. In a survey of pharmaceutical Senior Managers it was reported that the majority of pharmaceutical companies had miscalculated demand for new medicines by up to 25%. Michael Lehmann, executive vice president of sales and marketing for Patheon, a global provider of outsourced pharmaceutical development and manufacturing said, “Making accurate demand forecasts is extremely challenging for pharmaceutical companies”.